Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

Bloom J, Metz C, Nalawade S, Casabar J, Cheng KF, He M, Sherry B, Coleman T, Forsthuber T, Al-Abed Y.

J Biol Chem. 2016 Dec 16;291(51):26502-26514. Epub 2016 Oct 28.

PMID:
27793992
2.

Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.

Kanemitsu H, Matsunawa M, Wakabayashi K, Sato M, Takahashi R, Odai T, Isozaki T, Yajima N, Miwa Y, Kasama T.

Open Access Rheumatol. 2009 Mar 13;1:1-8. eCollection 2009.

3.

Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease.

Granata S, Dalla Gassa A, Bellin G, Lupo A, Zaza G.

Biomed Res Int. 2016;2016:9290857. doi: 10.1155/2016/9290857. Epub 2016 Jun 21. Review.

5.

Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1β production in a murine model of acute gout.

Galvão I, Dias AC, Tavares LD, Rodrigues IP, Queiroz-Junior CM, Costa VV, Reis AC, Ribeiro Oliveira RD, Louzada-Junior P, Souza DG, Leng L, Bucala R, Sousa LP, Bozza MT, Teixeira MM, Amaral FA.

J Leukoc Biol. 2016 Jun;99(6):1035-43. doi: 10.1189/jlb.3MA0915-418R. Epub 2016 Feb 11.

6.

Effectiveness of rosiglitazone in reducing flexion contracture in a rabbit model of arthrofibrosis with surgical capsular release: A biomechanical, histological, and genetic analysis.

Barlow JD, Morrey ME, Hartzler RU, Arsoy D, Riester S, van Wijnen AJ, Morrey BF, Sanchez-Sotelo J, Abdel MP.

Bone Joint Res. 2016 Jan;5(1):11-7. doi: 10.1302/2046-3758.51.2000593.

7.

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus.

Lang T, Foote A, Lee JP, Morand EF, Harris J.

Front Immunol. 2015 Nov 11;6:577. doi: 10.3389/fimmu.2015.00577. eCollection 2015. Review.

8.

The pathogenic role of angiogenesis in rheumatoid arthritis.

Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S.

Angiogenesis. 2015 Oct;18(4):433-48. doi: 10.1007/s10456-015-9477-2. Epub 2015 Jul 22. Review.

9.

Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.

Lourenco S, Teixeira VH, Kalber T, Jose RJ, Floto RA, Janes SM.

J Immunol. 2015 Apr 1;194(7):3463-74. doi: 10.4049/jimmunol.1402097. Epub 2015 Feb 23.

10.

Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis.

Singh A, Leng L, Fan J, Gajda M, Bräuer R, Fingerle-Rowson G, Bucala R, Illges H.

Rheumatol Int. 2013 Sep;33(9):2301-8. doi: 10.1007/s00296-013-2713-4. Epub 2013 Mar 17.

11.

A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).

Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, Aristoff PA, Leng L, Koski RA, Powell TJ, Bucala R, Anthony KG.

J Biol Chem. 2012 Aug 31;287(36):30653-63. doi: 10.1074/jbc.M112.385583. Epub 2012 Jul 10.

12.

Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis.

Meier FM, Frommer KW, Peters MA, Brentano F, Lefèvre S, Schröder D, Kyburz D, Steinmeyer J, Rehart S, Gay S, Müller-Ladner U, Neumann E.

J Biol Chem. 2012 Aug 17;287(34):28378-85. doi: 10.1074/jbc.M111.312884. Epub 2012 Jul 5.

13.

Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Alam A, Haldar S, Thulasiram HV, Kumar R, Goyal M, Iqbal MS, Pal C, Dey S, Bindu S, Sarkar S, Pal U, Maiti NC, Bandyopadhyay U.

J Biol Chem. 2012 Jul 13;287(29):24844-61. doi: 10.1074/jbc.M112.341321. Epub 2012 May 29.

14.

Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.

Alexander JK, Cox GM, Tian JB, Zha AM, Wei P, Kigerl KA, Reddy MK, Dagia NM, Sielecki T, Zhu MX, Satoskar AR, McTigue DM, Whitacre CC, Popovich PG.

Exp Neurol. 2012 Aug;236(2):351-62. doi: 10.1016/j.expneurol.2012.04.018. Epub 2012 May 1.

15.

Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension.

Zhang B, Shen M, Xu M, Liu LL, Luo Y, Xu DQ, Wang YX, Liu ML, Liu Y, Dong HY, Zhao PT, Li ZC.

Mediators Inflamm. 2012;2012:840737. doi: 10.1155/2012/840737. Epub 2012 Jan 18. Review.

16.

Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.

Kasama T, Ohtsuka K, Sato M, Takahashi R, Wakabayashi K, Kobayashi K.

Arthritis. 2010;2010:106202. doi: 10.1155/2010/106202. Epub 2010 Dec 26.

17.
18.

Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1.

Ralph JA, Ahmed AU, Santos LL, Clark AR, McMorrow J, Murphy EP, Morand EF.

Am J Pathol. 2010 Nov;177(5):2366-78. doi: 10.2353/ajpath.2010.091204. Epub 2010 Sep 9.

19.

Rheumatoid arthritis-associated gene-gene interaction network for rheumatoid arthritis candidate genes.

Huang CH, Cong L, Xie J, Qiao B, Lo SH, Zheng T.

BMC Proc. 2009 Dec 15;3 Suppl 7:S75.

20.

Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.

Elsby LM, Donn R, Alourfi Z, Green LM, Beaulieu E, Ray DW.

Arthritis Rheum. 2009 Aug;60(8):2220-31. doi: 10.1002/art.24659.

Supplemental Content

Support Center